We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Orexigen, Takeda Sue Actavis Over Anti-Obesity Drug Contrave
Orexigen, Takeda Sue Actavis Over Anti-Obesity Drug Contrave
Orexigen Therapeutics and Takeda filed a patent infringement suit in federal court aimed at blocking Actavis from marketing a generic version of their anti-obesity drug Contrave.